Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

FDA Focuses on Drugs and Liver Damage
JAMA, 07/22/09

Kuehn BM – The US Food and Drug Administration (FDA) is working to reduce drug–induced liver damage with an initiative targeting the use of acetaminophen—the most common cause of such adverse events. The agency also is promoting research on genetic factors that may contribute to drug–related liver problems.

Related Articles

Acetaminophen poisoning: Case Report
The Internet Journal of Toxicology, 11/02/09    Relevance Score: 88%

Acetaminophen Use and the Risk of Asthma in Children and Adults
Chest, 10/06/09    Relevance Score: 87%

Acetaminophen has limited antipyretic activity in critically ill patients
Journal of Critical Care, 10/02/09    Relevance Score: 87%

Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban, low-income cohort
Thorax, 11/10/09    Relevance Score: 85%

Antiemetic use in acetaminophen poisoning: How does the route of N-acetylcysteine administration affect utilization
Journal of Medical Toxicology, 11/06/09    Relevance Score: 85%

Today in Regulatory Issues...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

 See all of Regulatory Issues

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address